BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26966495)

  • 21. An ACVR1
    Kaplan FS; Groppe JC; Xu M; Towler OW; Grunvald E; Kalunian K; Kallish S; Al Mukaddam M; Pignolo RJ; Shore EM
    Am J Med Genet A; 2022 Mar; 188(3):806-817. PubMed ID: 34854557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACVR1 gene mutations in four Turkish patients diagnosed as fibrodysplasia ossificans progressiva.
    Eresen Yazıcıoğlu C; Karatosun V; Kızıldağ S; Ozsoylu D; Kavukçu S
    Gene; 2013 Feb; 515(2):444-6. PubMed ID: 23260810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report.
    Nakahara Y; Katagiri T; Ogata N; Haga N
    Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene.
    Cappato S; Traberg R; Gintautiene J; Zara F; Bocciardi R
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1774. PubMed ID: 34347384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
    Shore EM; Xu M; Feldman GJ; Fenstermacher DA; Cho TJ; Choi IH; Connor JM; Delai P; Glaser DL; LeMerrer M; Morhart R; Rogers JG; Smith R; Triffitt JT; Urtizberea JA; Zasloff M; Brown MA; Kaplan FS
    Nat Genet; 2006 May; 38(5):525-7. PubMed ID: 16642017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva.
    Lee DY; Cho TJ; Lee HR; Park MS; Yoo WJ; Chung CY; Choi IH
    J Korean Med Sci; 2009 Jun; 24(3):433-7. PubMed ID: 19543505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrodysplasia ossificans progressiva.
    Shaikh N; Arif F
    J Pak Med Assoc; 2011 Apr; 61(4):397-9. PubMed ID: 21465984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva.
    Chakkalakal SA; Zhang D; Culbert AL; Convente MR; Caron RJ; Wright AC; Maidment AD; Kaplan FS; Shore EM
    J Bone Miner Res; 2012 Aug; 27(8):1746-56. PubMed ID: 22508565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report.
    Wang Z; Wang X; Liu B; Hou Y
    Medicine (Baltimore); 2021 Mar; 100(9):e24620. PubMed ID: 33655926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1
    Maruyama R; Nguyen Q; Roshmi RR; Touznik A; Yokota T
    Nucleic Acid Ther; 2022 Jun; 32(3):185-193. PubMed ID: 35085461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A recurrent mutation c.617G>A in the ACVR1 gene causes fibrodysplasia ossificans progressiva in two Chinese patients.
    Sun Y; Xia W; Jiang Y; Xing X; Li M; Wang O; Zhang H; Hu Y; Liu H; Meng X; Zhou X
    Calcif Tissue Int; 2009 May; 84(5):361-5. PubMed ID: 19300893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene.
    Huang X; Roeder A; Li R; Beers J; Liu C; Zou J; Yu PB; Zheng W
    Stem Cell Res; 2021 Jul; 54():102424. PubMed ID: 34139597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
    Chakkalakal SA; Shore EM
    Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients.
    Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC
    Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS; Shen Q; Lounev V; Seemann P; Groppe J; Katagiri T; Pignolo RJ; Shore EM
    J Bone Miner Metab; 2008; 26(6):521-30. PubMed ID: 18979151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrodysplasia ossificans progressiva.
    Kaplan FS; Le Merrer M; Glaser DL; Pignolo RJ; Goldsby RE; Kitterman JA; Groppe J; Shore EM
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):191-205. PubMed ID: 18328989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.
    Towler OW; Shore EM; Kaplan FS
    Bone; 2020 Jan; 130():115116. PubMed ID: 31655222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrodysplasia ossificans progressiva (stone man syndrome): a case report.
    Shah ZA; Rausch S; Arif U; El Yafawi B
    J Med Case Rep; 2019 Dec; 13(1):364. PubMed ID: 31785620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.
    Kawao N; Yano M; Tamura Y; Okumoto K; Okada K; Kaji H
    J Bone Miner Metab; 2016 Sep; 34(5):517-25. PubMed ID: 26204847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva.
    Shore EM; Kaplan FS
    Curr Osteoporos Rep; 2011 Jun; 9(2):83-8. PubMed ID: 21340697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.